Immupharma Share Discussion Threads

[joeblogg2] 03/6/2019 11:19

Nobby thks for that but even so Lupuzor safety and less side effects to the other drugs not taken into consideration ??

[todpodger] 03/6/2019 11:10

The share price should steadily rise this month in anticipation of impending good news.have increased holding don't want to get caught out.

[brad44] 30/5/2019 19:41

so why are you here? weve all moved on from that..and i cant remember how many times you have posted the above, we all know your opinion..move on, get a life, enjoy your new found hero worship on Opti..

[nobbygnome] 30/5/2019 17:18

>> joe

The placebo group were taking SOC drugs as well as the placebo injection so in fact the trial proved that Lupuzor showed no extra benefit on top of those drugs. That's the statistical reality...

[joeblogg2] 30/5/2019 16:46

The problem was it worked but so did the placebo during then trial!!! There was little difference between the two but if a patient thought he was taking a placebo, then they probably would not have reacted as well!!!

[lord loads of lolly] 30/5/2019 16:27

I actually think his tone sounds less gung ho than normal. Which may not be a good sign! Hope I'm wrong though, speaking as a long-suffering holder. To think I hovered over that Sell button just before Phase III results and could have exited with a tidy profit. Guess that's what comes of being greedy.

[kirk 6] 30/5/2019 16:15

Totally agree just imagine if Tim turned this around back from failure to success

[miavoce] 30/5/2019 12:20

This bit from the interview link posted by astonedt seems very positive, and maybe (if it has been available) the data from the extension study has contributed to this renewed interest. The expectation of seeing some movement around Lupuzor over the next few months indicates that some discussions are well advanced...maybe good news to come soon providing Tim isn't being over optimistic (again).


"What we are seeing is an awful lot of renewed interest in Lupuzor, we as a company are very much concentrated on the paths to market for Lupuzor so that’s both the development pathway and also the regulatory pathway.
With a lot of the data, obviously now being examined form that Phase III study, it’s showing us an awful lot of very good signs and that is what other people are seeing as well so we’ve had a number of discussions ongoing for a little while now. Those discussions are starting to come to fruition so we are expecting to see some movement in and around Lupuzor over the next few months so we’ll see where that gets us but it’s looking quite good at the moment."

[joeblogg2] 30/5/2019 12:06

I would have thought they had access as this trial as giving the drug and not any placebo? Have taken a small position and hope it comes good as lost a considerable amount last time round.

[miavoce] 30/5/2019 11:56

Regarding the extension study which is due to report next month, will IMM have had access to the data as the study progressed or is it released to them at the conclusion of the study ?

[kirk 6] 30/5/2019 11:43

Close your short at 22.5p mate

[ken chung] 30/5/2019 09:00

But Imm will now only have a small interest in the rest of the pipeline after it is put I to a separate company, so that has in effect diluted Imm shareholders interests.Imm just left with failed Lupuzor which is worthless and no chance of raising more cash.

[ny boy] 30/5/2019 08:59

Yes enough to keep me interested here, got some 10p & around 30p, happy to stay patient, I have done with STX! Also HEMO, ITX, FUL & MSYS are looking good for long term rewards

[kirk 6] 29/5/2019 10:44

And againBy spinning them out, without further dilution to shareholders and potentially unlocking an awful lot of value, recognised value, in those two technologies, that then should flow back into recognition in the share price on AIM plus whatever we do with Lupuzor in the future.So, I think some pretty good stuff coming up in the future, very much.

[kirk 6] 29/5/2019 10:43

This bit reads extremely well possible complete turnaround to last years highs?ny drug of this type.What we are seeing is an awful lot of renewed interest in Lupuzor, we as a company are very much concentrated on the paths to market for Lupuzor so that's both the development pathway and also the regulatory pathway.With a lot of the data, obviously now being examined form that Phase III study, it's showing us an awful lot of very good signs and that is what other people are seeing as well so we've had a number of discussions ongoing for a little while now. Those discussions are starting to come to fruition so we are expecting to see some movement in and around Lupuzor over the next few months so we'll see where that gets us but it's looking quite good at the mome

[geraldus] 28/5/2019 19:41

Another Proactive video out today starring TM.

[linesal2] 27/5/2019 14:49

Ken chung you spreading doom and gloom here as well!!!Sad little man

[sicilian_kan] 22/5/2019 12:36

Why would the directors, who own >20% of Immupharma, put it into administration? What a ridiculous suggestion.

The reality is that if the current strategy is executed Immupharma would in effect be a holding company.

A) It would own license revenues for P140 / Lupuzor
B) It would own shares in the floated Urelix / Nucant subsidiary
C) It would own shares in Incathera

All those are potentially very valuable assets. A) and B) in particular.

[ken chung] 22/5/2019 12:08

If they float off the rest of the pipeline into another company as planned, that just leaves IMM with Lupuzor which failed Phase 3, so presumably then IMM can be put into administration, and the management just transfer over to the new company to repeat the same old rinse and repeat share issue-dilution-failure process to unsuspecting French investors this time rather than trying to return to the London market.You couldn't make it up.

[kop202] 21/5/2019 14:07

Is Kirk Tim McCarthy?......the ramping seems familiar

[reks] 21/5/2019 10:18

just turned blue - big background buyer

[kirk 6] 21/5/2019 09:09

Massive potential upside here

[reks] 20/5/2019 17:14

start of the rerate? if results good it could blow the price away

rise in anticipation i suppose

[kirk 6] 20/5/2019 16:42

These you go 10.5